Rating scales
MHCOVID - an online "living" systematic review on changes in the prevalence of mental health problems due to the COVID-19 pandemic and the measures taken to limit them
The project was funded by the Swiss National Science Foundation (SNSF) as part of the NRP 78 initiative.
We assume that both the length and intensity of social isolation in the context of physical distancing measures and the fear of infection can have serious negative effects on the mental health of the general population. However, a comprehensive evidence base is currently lacking, meaning that this assumption can neither be confirmed nor refuted. It is currently unclear a) how high the prevalence of mental health problems is in the general population and in specific subgroups worldwide in the various phases of the COVID-19 pandemic, b) whether and how the extent of the pandemic and the intensity of the measures taken to contain the pandemic affect the psyche and c) which characteristics of the population and context modify this influence on the psyche.
We systematically record all published studies worldwide that measure the impact of the pandemic on mental health in the general population using standardized instruments. As of February 2022, we have recruited 117 experienced physicians, psychologists, statisticians and students as volunteers, which has enabled us to screen more than 40,000 publications for relevance and extract extensive data sets from almost 300 articles on a specially adapted online platform. We present regular updates of our results on our website.
For more information on the project and how to participate, please visit: mhcovid.ispm.unibe.ch/crowd.html
Contact us by email (natalie.peter@tum.de) or on Twitter: @MH_COVID!
The study protocol was pre-registered on Prospero under the number CRD42020180049 (see here).
In addition to contributions at conferences and on the radio, the project has so far been published in an editorial in European Archives of Psychiatry and Clinical Neuroscience:
Leucht S, Cipriani A, Furukawa TA, Peter N, Tonia T, Papakonstantinou T, Holloway A, Salanti G. A living meta-ecological study of the consequences of the COVID-19 pandemic on mental health. Eur Arch Psychiatry Clin Neurosci 271, 219-221 (2021). Link
As presented in a commentary in Lancet Psychiatry:
Salanti G, Cipriani A, Furukawa TA, Peter N, Tonia T, Papakonstantinou T, Holloway A, Leucht S. An efficient way to assess the effect of COVID-19 on mental health in the general population. The Lancet Psychiatry 8 (5), e14-e15 (2021). Link
- Treatment-resistant schizophrenia - psychotherapy
- Samidorphan
- Blonanserin
- AGITAR
- FISHER
- Mental Health Covid
- ShARPP
- Antipsychotics acute
- Injectable vs oral application
- Treatment-resistant schizophrenia
- ClozapineIPD
- Metabolic
- Dose-and-polypharmacy-reduction
- Cognition
- Antipsychotic medications: western and Chinese studies